Biotech · Private company
Changchun GeneScience Pharmaceutical Co., Ltd.
Track this companyFree. Adds Changchun GeneScience Pharmaceutical Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- GenotropinPhase 3 · GHDClinicalTrials.gov · fetched Nov 12, 2026
- GenSci004Phase 3 · GHDClinicalTrials.gov · fetched Nov 12, 2026
- GenSci143 for injectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- GenSci143 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Dec 20, 2025ClinicalTrials.gov NCT07252414 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone DeficiencyPHASE3 · UNKNOWN · started Dec 1, 2023ClinicalTrials.gov NCT06007417 · fetched Nov 12, 2026
- Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious PubertyPHASE3 · COMPLETED · started Jun 2, 2023ClinicalTrials.gov NCT05493709 · fetched Nov 12, 2026